ZIOPHARM ONCOLOGY INC Business Operations Contracts & Agreements

16 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Fourth Amendment to the Cooperative Research and Development Agreement, dated June 24, 2022, by and between the National Cancer Institute and the Registrant
Development Agreements
ZIOPHARM ONCOLOGY INC
Biotechnology
2022
Third Amendment to the Cooperative Research and Development Agreement, dated March 15, 2022, by and among the National Cancer Institute and the Registrant
Development Agreements
ZIOPHARM ONCOLOGY INC
Biotechnology
2022
Agreement, by and among ZIOPHARM Oncology, Inc., WaterMill Asset Management Corp. Robert W. Postma, Jamie Vieser, and Holger Weis, dated February 4, 2021
Management Agreements
ZIOPHARM ONCOLOGY INC
Biotechnology
DE
2021
2019 Research and Development Agreement, dated October 22, 2019, by and between the Registrant and The University of Texas MD Anderson Cancer Center
Development Agreements
ZIOPHARM ONCOLOGY INC
Biotechnology
TX
2020
Fifth Amendment to Research and Development Agreement, dated October 22, 2019 by and among the Registrant and The University of Texas MD Anderson Cancer Center
Development Agreements
ZIOPHARM ONCOLOGY INC
Biotechnology
2020
Fourth Amendment to Research and Development Agreement, dated September 19, 2019 by and between the Registrant, The University of Texas MD Anderson Cancer Center and Precigen, Inc
Development Agreements
ZIOPHARM ONCOLOGY INC
Biotechnology
2019
Amendment #2 to the Cooperative Research and Development Agreement, dated February 1, 2019, by and among the National Cancer Institute, Ziopharm Oncology, Inc. and Precigen, Inc
Development Agreements
ZIOPHARM ONCOLOGY INC
Biotechnology
2019
Amendment #1 to the Cooperative Research and Development Agreement, dated March 23, 2018, by and among the National Cancer Institute, Ziopharm Oncology, Inc., Intrexon Corporation...
Development Agreements
ZIOPHARM ONCOLOGY INC
Biotechnology
2019
Cooperative Research and Development Agreement, dated January 9, 2017, by and among the National Cancer Institute, Ziopharm Oncology, Inc. and Intrexon Corporation
Development Agreements
ZIOPHARM ONCOLOGY INC
Biotechnology
DC
2019
Placement Agency Agreement, dated July 26, 2019, by and among Ziopharm Oncology, Inc. and Raymond James & Associates, Inc
Agency Agreements
ZIOPHARM ONCOLOGY INC
Biotechnology
NY
2019
Amendment #3 to the Research and Development Agreement by and among the Registrant, Intrexon Corporation and The University of Texas M.D. Anderson Cancer Center dated as of...
Development Agreements
ZIOPHARM ONCOLOGY INC
Biotechnology
2019
Amendment #2 to the Research and Development Agreement by and among the Registrant, Intrexon Corporation and The University of Texas M.D. Anderson Cancer Center dated as of...
Development Agreements
ZIOPHARM ONCOLOGY INC
Biotechnology
2019
Amendment #1 to the Research and Development Agreement by and among the Registrant, Intrexon Corporation and The University of Texas M.D. Anderson Cancer Center dated as of August...
Development Agreements
ZIOPHARM ONCOLOGY INC
Biotechnology
2019
Placement Agency Agreement, dated November 11, 2018, by and among Ziopharm Oncology, Inc. and Raymond James & Associates, Inc
Agency Agreements
ZIOPHARM ONCOLOGY INC
Biotechnology
NY
2018
EXCLUSIVE CHANNEL COLLABORATION AGREEMENT
Collaboration Agreements
ZIOPHARM ONCOLOGY INC
Biotechnology
NY
2015
RESEARCH AND DEVELOPMENT AGREEMENT
Development Agreements
ZIOPHARM ONCOLOGY INC
Biotechnology
TX
2015